Targeting epigenetic readers in cancer - PubMed (original) (raw)

Review

. 2012 Aug 16;367(7):647-57.

doi: 10.1056/NEJMra1112635.

Affiliations

• PMID: 22894577
• DOI: 10.1056/NEJMra1112635

Review

Targeting epigenetic readers in cancer

Mark A Dawson et al. N Engl J Med. 2012.

No abstract available

PubMed Disclaimer

Comment in

• Targeting epigenetic readers in cancer.
  Rosner M, Hengstschläger M. Rosner M, et al. N Engl J Med. 2012 Nov 1;367(18):1764-5. doi: 10.1056/NEJMc1211175. N Engl J Med. 2012. PMID: 23113498 No abstract available.

Similar articles

• Targeting epigenetic readers in cancer.
  Rosner M, Hengstschläger M. Rosner M, et al. N Engl J Med. 2012 Nov 1;367(18):1764-5. doi: 10.1056/NEJMc1211175. N Engl J Med. 2012. PMID: 23113498 No abstract available.
• Chromatin modulation by oncogenic transcription factors: new complexity, new therapeutic targets.
  Hormaeche I, Licht JD. Hormaeche I, et al. Cancer Cell. 2007 Jun;11(6):475-8. doi: 10.1016/j.ccr.2007.05.005. Cancer Cell. 2007. PMID: 17560329 Review.
• Epigenetic Determinants of Cancer.
  Baylin SB, Jones PA. Baylin SB, et al. Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a019505. doi: 10.1101/cshperspect.a019505. Cold Spring Harb Perspect Biol. 2016. PMID: 27194046 Free PMC article. Review.
• The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer.
  Friedman JM, Jones PA, Liang G. Friedman JM, et al. Cell Cycle. 2009 Aug;8(15):2313-4. doi: 10.4161/cc.8.15.9168. Epub 2009 Aug 15. Cell Cycle. 2009. PMID: 19625769 Free PMC article. No abstract available.
• Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy.
  Amjadi-Moheb F, Paniri A, Akhavan-Niaki H. Amjadi-Moheb F, et al. Cancer Res. 2021 Apr 15;81(8):1925-1936. doi: 10.1158/0008-5472.CAN-20-3613. Epub 2021 Jan 20. Cancer Res. 2021. PMID: 33472888 Review.

Cited by

• Inhibition of BET bromodomain targets genetically diverse glioblastoma.
  Cheng Z, Gong Y, Ma Y, Lu K, Lu X, Pierce LA, Thompson RC, Muller S, Knapp S, Wang J. Cheng Z, et al. Clin Cancer Res. 2013 Apr 1;19(7):1748-59. doi: 10.1158/1078-0432.CCR-12-3066. Epub 2013 Feb 12. Clin Cancer Res. 2013. PMID: 23403638 Free PMC article.
• Comparative Study of the Immune Microenvironment in Heterotopic Tumor Models.
  Kienzl M, Maitz K, Sarsembayeva A, Valadez-Cosmes P, Gruden E, Ristic D, Herceg K, Kargl J, Schicho R. Kienzl M, et al. Cancers (Basel). 2024 Jan 10;16(2):295. doi: 10.3390/cancers16020295. Cancers (Basel). 2024. PMID: 38254785 Free PMC article.
• Epigenetics: the fine-tuner in inflammatory bowel disease?
  Stylianou E. Stylianou E. Curr Opin Gastroenterol. 2013 Jul;29(4):370-7. doi: 10.1097/MOG.0b013e328360bd12. Curr Opin Gastroenterol. 2013. PMID: 23743674 Free PMC article. Review.
• Epigenetic polypharmacology: from combination therapy to multitargeted drugs.
  de Lera AR, Ganesan A. de Lera AR, et al. Clin Epigenetics. 2016 Oct 12;8:105. doi: 10.1186/s13148-016-0271-9. eCollection 2016. Clin Epigenetics. 2016. PMID: 27752293 Free PMC article. Review.
• EpiDBase: a manually curated database for small molecule modulators of epigenetic landscape.
  Loharch S, Bhutani I, Jain K, Gupta P, Sahoo DK, Parkesh R. Loharch S, et al. Database (Oxford). 2015 Mar 16;2015:bav013. doi: 10.1093/database/bav013. Print 2015. Database (Oxford). 2015. PMID: 25776023 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database